New Clinical Standard Aims to Close the Diagnosis Gap for Obesity as a Chronic Disease
The integration of obesity recognition into routine clinical practice has taken a significant step forward with the introduction of a…
cancer
Amara Maple Early-life Exposure to Per- and Polyfluoroalkyl Substances and Adolescent Bone Mineral Density: Assessing Periods of Susceptibility
The pervasive presence of synthetic "forever chemicals" in the environment has long been a subject of intense scientific scrutiny, but…
Legacy of Excellence: The Life and Work of Professor Martin O. Savage, Pioneer of Pediatric Endocrinology
The global medical community is mourning the loss of Professor Martin O. Savage, Emeritus Professor of Pediatric Endocrinology at the…
Endocrine Society Advocacy Win: Congress Increases FY 2026 NIH Funding
The United States Congress has officially passed a comprehensive funding bill for the Department of Health and Human Services (HHS)…
Beyond the Scale: How GLP-1 Receptor Agonists are Redefining Metabolic Health Across Diverse Patient Populations
The clinical landscape of metabolic medicine is undergoing a seismic shift as glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed to…
High Body Mass Index and Hypertension Identified as Direct Causal Factors in the Development of Vascular-Related Dementia
A landmark study published in The Journal of Clinical Endocrinology & Metabolism (JCEM) has provided definitive evidence linking obesity and…
Advancing Endocrine Science: A Deep Dive into the Endocrine Society’s Strategic Initiatives for Presenting Publishing and Professional Mentorship
The Endocrine Society, a premier global organization representing over 18,000 professionals in the field of hormone research and clinical endocrinology,…
Endocrine Society Announces 2026 Laureate Award Winners and New Clinical Advancements in Thyroid Treatment and Global Research Infrastructure
The Endocrine Society has officially launched its January 2026 programming, marking the beginning of the year with a comprehensive tribute…
Oral Semaglutide 25 mg Receives FDA Approval for Chronic Weight Management Marking a New Era in Metabolic Health
The landscape of metabolic medicine underwent a significant transformation in early January 2026 as the 25 mg oral formulation of…
Endocrine Society Launches Rare Endocrine Disease Fellows Program to Bridge Critical Gaps in Specialist Education and Patient Care
The Endocrine Society has officially announced the commencement of its Rare Endocrine Disease (RED) Fellows Program, a specialized educational initiative…